Run Tang, Cheng Wang, Yingxiang Zhu, Kai Liu, Zeming Wu. "SLC45A2 drives prostate cancer progression through tumor promotion and immune suppression." Scientific Reports, 2025. doi:10.1038/s41598-025-32340-z